Weight-loss drug could reduce risk of heart attacks by 20%, new study finds

Study suggests those with mild obesity or who have lost only a small amount of weight could have an improved cardiovascular outcome.

A weight-loss injection could reduce the risk of heart attacks and benefit cardiovascular health in what could be the largest medical breakthrough since statins, according to a study.

It found participants taking the medication semaglutide, the active ingredient in brands including Wegovy and Ozempic, had a 20% lower risk of heart attack, stroke, or death due to cardiovascular disease.